CEVA INC (CEVA)

US1572101053 - Common Stock

32.27  +0.45 (+1.41%)

After market: 32.27 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CEVA. CEVA was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. CEVA has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, CEVA is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

In the past year CEVA was profitable.
CEVA had a positive operating cash flow in the past year.
CEVA had negative earnings in 4 of the past 5 years.
Of the past 5 years CEVA 4 years had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.08%, CEVA is in line with its industry, outperforming 43.52% of the companies in the same industry.
Looking at the Return On Equity, with a value of -1.23%, CEVA is in line with its industry, outperforming 43.52% of the companies in the same industry.
Industry RankSector Rank
ROA -1.08%
ROE -1.23%
ROIC N/A
ROA(3y)-3.77%
ROA(5y)-2.42%
ROE(3y)-4.44%
ROE(5y)-2.85%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CEVA (88.56%) is better than 99.07% of its industry peers.
CEVA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CEVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 88.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.38%

8

2. Health

2.1 Basic Checks

CEVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CEVA has more shares outstanding
Compared to 5 years ago, CEVA has more shares outstanding
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 12.70 indicates that CEVA is not in any danger for bankruptcy at the moment.
CEVA's Altman-Z score of 12.70 is amongst the best of the industry. CEVA outperforms 82.41% of its industry peers.
CEVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 12.7
ROIC/WACCN/A
WACC14.73%

2.3 Liquidity

CEVA has a Current Ratio of 7.60. This indicates that CEVA is financially healthy and has no problem in meeting its short term obligations.
CEVA's Current ratio of 7.60 is amongst the best of the industry. CEVA outperforms 91.67% of its industry peers.
A Quick Ratio of 7.60 indicates that CEVA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 7.60, CEVA belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.6
Quick Ratio 7.6

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 56.52% over the past year.
CEVA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.63% yearly.
The Revenue has decreased by -4.48% in the past year.
Measured over the past years, CEVA shows a small growth in Revenue. The Revenue has been growing by 4.57% on average per year.
EPS 1Y (TTM)56.52%
EPS 3Y-44.66%
EPS 5Y-28.63%
EPS Q2Q%600%
Revenue 1Y (TTM)-4.48%
Revenue growth 3Y-0.97%
Revenue growth 5Y4.57%
Sales Q2Q%13.02%

3.2 Future

Based on estimates for the next years, CEVA will show a very strong growth in Earnings Per Share. The EPS will grow by 105.43% on average per year.
The Revenue is expected to grow by 7.21% on average over the next years.
EPS Next Y271.28%
EPS Next 2Y136.42%
EPS Next 3Y105.43%
EPS Next 5YN/A
Revenue Next Year-1.02%
Revenue Next 2Y4.3%
Revenue Next 3Y7.21%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 89.64, CEVA can be considered very expensive at the moment.
CEVA's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of CEVA to the average of the S&P500 Index (27.54), we can say CEVA is valued expensively.
A Price/Forward Earnings ratio of 57.73 indicates a quite expensive valuation of CEVA.
CEVA's Price/Forward Earnings ratio is in line with the industry average.
CEVA is valuated expensively when we compare the Price/Forward Earnings ratio to 23.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 89.64
Fwd PE 57.73

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CEVA's earnings are expected to grow with 105.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y136.42%
EPS Next 3Y105.43%

0

5. Dividend

5.1 Amount

No dividends for CEVA!.
Industry RankSector Rank
Dividend Yield N/A

CEVA INC

NASDAQ:CEVA (12/24/2024, 8:02:35 PM)

After market: 32.27 0 (0%)

32.27

+0.45 (+1.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-12 2025-02-12/amc
Inst Owners88.4%
Inst Owner Change2.13%
Ins Owners2.22%
Ins Owner Change6.22%
Market Cap762.54M
Analysts81.67
Price Target33.49 (3.78%)
Short Float %3.38%
Short Ratio4.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)327.8%
Min EPS beat(2)41.21%
Max EPS beat(2)614.39%
EPS beat(4)3
Avg EPS beat(4)109.17%
Min EPS beat(4)-288.54%
Max EPS beat(4)614.39%
EPS beat(8)4
Avg EPS beat(8)24.34%
EPS beat(12)7
Avg EPS beat(12)18.04%
EPS beat(16)10
Avg EPS beat(16)19.67%
Revenue beat(2)1
Avg Revenue beat(2)6.61%
Min Revenue beat(2)-0.66%
Max Revenue beat(2)13.87%
Revenue beat(4)1
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-6.45%
Max Revenue beat(4)13.87%
Revenue beat(8)2
Avg Revenue beat(8)-4.53%
Revenue beat(12)4
Avg Revenue beat(12)-6.27%
Revenue beat(16)8
Avg Revenue beat(16)-2.02%
PT rev (1m)17.96%
PT rev (3m)17.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-39.78%
EPS NY rev (1m)4.54%
EPS NY rev (3m)12.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.01%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 89.64
Fwd PE 57.73
P/S 7.48
P/FCF N/A
P/OCF 3203.96
P/B 2.87
P/tB 3.71
EV/EBITDA N/A
EPS(TTM)0.36
EY1.12%
EPS(NY)0.56
Fwd EY1.73%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)0.01
OCFY0.03%
SpS4.31
BVpS11.25
TBVpS8.69
PEG (NY)0.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.08%
ROE -1.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 88.56%
FCFM N/A
ROA(3y)-3.77%
ROA(5y)-2.42%
ROE(3y)-4.44%
ROE(5y)-2.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-0.38%
F-Score7
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 87.1%
Cap/Sales 3.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.6
Quick Ratio 7.6
Altman-Z 12.7
F-Score7
WACC14.73%
ROIC/WACCN/A
Cap/Depr(3y)45.58%
Cap/Depr(5y)78.55%
Cap/Sales(3y)2.45%
Cap/Sales(5y)4.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.52%
EPS 3Y-44.66%
EPS 5Y-28.63%
EPS Q2Q%600%
EPS Next Y271.28%
EPS Next 2Y136.42%
EPS Next 3Y105.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.48%
Revenue growth 3Y-0.97%
Revenue growth 5Y4.57%
Sales Q2Q%13.02%
Revenue Next Year-1.02%
Revenue Next 2Y4.3%
Revenue Next 3Y7.21%
Revenue Next 5YN/A
EBIT growth 1Y15.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year352.83%
EBIT Next 3Y119.43%
EBIT Next 5YN/A
FCF growth 1Y-129.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-98.36%
OCF growth 3YN/A
OCF growth 5YN/A